To test this hypothesis, we analyzed the glycolytic function and OXPHOS of CD4+ T cells isolated from PBMC of P1 and a HD control that were stimulated with anti‐CD3/CD28 in the presence or absence of the calcineurin inhibitor FK506 for 24 h. The gene discussed is CD28; the disease is Huntington disease.